Diversify Wealth Management LLC Boosts Position in The Cooper Companies, Inc. (NASDAQ:COO)

Diversify Wealth Management LLC boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 19.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,323 shares of the medical device company's stock after buying an additional 3,534 shares during the quarter. Diversify Wealth Management LLC's holdings in Cooper Companies were worth $1,753,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in COO. Covestor Ltd grew its position in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after buying an additional 120 shares during the period. Shell Asset Management Co. grew its position in Cooper Companies by 15.5% in the 4th quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock valued at $87,000 after purchasing an additional 127 shares during the period. UMB Bank n.a. grew its position in Cooper Companies by 16.7% in the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock valued at $76,000 after purchasing an additional 129 shares during the period. Axxcess Wealth Management LLC grew its position in Cooper Companies by 1.9% in the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock valued at $623,000 after purchasing an additional 140 shares during the period. Finally, Mitchell & Pahl Private Wealth LLC grew its position in Cooper Companies by 1.8% in the 1st quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock valued at $732,000 after purchasing an additional 157 shares during the period. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Stock Performance

Cooper Companies stock traded down $1.93 during midday trading on Friday, reaching $74.77. The stock had a trading volume of 2,517,933 shares, compared to its average volume of 1,741,694. The Cooper Companies, Inc. has a 12 month low of $65.00 and a 12 month high of $112.38. The firm's 50-day moving average price is $74.92 and its 200 day moving average price is $82.71. The firm has a market capitalization of $14.95 billion, a PE ratio of 36.30, a P/E/G ratio of 1.87 and a beta of 0.99. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. The business had revenue of $1 billion for the quarter, compared to analysts' expectations of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The firm's quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.85 EPS. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently issued reports on COO. Needham & Company LLC raised shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price target for the company in a research report on Tuesday, June 17th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $76.00 price target (down previously from $110.00) on shares of Cooper Companies in a research report on Friday, May 30th. Wells Fargo & Company reduced their price target on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a research report on Friday, May 30th. Loop Capital set a $100.00 price objective on Cooper Companies in a research note on Tuesday, June 17th. Finally, Piper Sandler restated an "overweight" rating and set a $105.00 price objective (down from $115.00) on shares of Cooper Companies in a research note on Friday, May 30th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $99.70.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.